Discovery of indane propanamides as potent and selective TRPV1 antagonists

被引:12
|
作者
Ahn, Songyeon [1 ]
Kim, Yong Soo [1 ]
Kim, Myeong Seup [1 ]
Ann, Jihyae [1 ]
Ha, Heejin [2 ]
Yoo, Young Dong [2 ]
Kim, Young Ho [2 ]
Blumberg, Peter M. [3 ]
Frank-Foltyn, Robert [4 ]
Bahrenberg, Gregor [4 ]
Stockhausen, Hannelore [4 ]
Christoph, Thomas [4 ]
Lee, Jeewoo [1 ]
机构
[1] Seoul Natl Univ, Coll Pharm, Lab Med Chem, Seoul 08826, South Korea
[2] Medifron DBT, Ansan 15426, Gyeonggi Do, South Korea
[3] NCI, Lab Canc Biol & Genet, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
[4] Grunenthal GmbH, Grunenthal Innovat, D-52078 Aachen, Germany
基金
新加坡国家研究基金会;
关键词
Vanilloid receptor 1; TRPV1; antagonist; Analgesic; C-REGION ANALOGS; VANILLOID-1; ANTAGONISTS; CAPSAICIN RECEPTOR; 2-(3-FLUORO-4-METHYLSULFONYLAMINOPHENYL)PROPANAMIDES; PYRIDINE; PAIN; 2-(3-FLUORO-4-METHYLSULFONAMIDOPHENYL)PROPANAMIDES; PHARMACOLOGY;
D O I
10.1016/j.bmcl.2019.126838
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of indane-type acetamide and propanamide analogues were investigated as TRPV1 antagonists. The analysis of structure-activity relationship indicated that indane A-region analogues exhibited better antagonism than did the corresponding 2,3-dihydrobenzofuran and 1,3-benzodioxole surrogates. Among them, antagonist 36 exhibited potent and selective antagonism toward capsaicin for hTRPV1 and mTRPV1. Further, in vivo studies indicated that antagonist 36 showed excellent analgesic activity in both phases of the formalin mouse pain model and inhibited the pain behavior completely at a dose of 1 mg/kg in the 2nd phase.
引用
收藏
页数:5
相关论文
共 50 条
  • [41] 4-(2-Pyridyl)piperazine-1-benzimidazoles as potent TRPV1 antagonists
    Shao, B
    Huang, JC
    Sun, Q
    Valenzano, KJ
    Schmid, L
    Nolan, S
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (03) : 719 - 723
  • [42] Discovery of N-(1,4-Benzoxazin-3-one) urea analogs as Mode-Selective TRPV1 antagonists
    Huang, Guocheng
    Jung, Aeran
    Li, Li-Xuan
    Do, Nayeon
    Jung, Sungwon
    Jeon, Yubum
    Zuo, Dongxu
    La, Minh Thanh
    Manh, Nguyen Van
    Blumberg, Peter M.
    Yoon, Hongryul
    Lee, Yoonji
    Ann, Jihyae
    Lee, Jeewoo
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2024, 106
  • [43] 2-(3-Fluoro-4-methylsulfonylaminophenyl)propanamides as potent TRPV1 antagonists: Structure activity relationships of the 2-oxy pyridine C-region
    Thorat, Shivaji A.
    Kang, Dong Wook
    Ryu, HyungChul
    Kim, Myeong Seop
    Kim, Ho Shin
    Ann, Jihyae
    Ha, Taehwan
    Kim, Sung-Eun
    Son, Karam
    Choi, Sun
    Blumberg, Peter M.
    Frank, Robert
    Bahrenberg, Gregor
    Schiene, Klaus
    Christoph, Thomas
    Lee, Jeewoo
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2013, 64 : 589 - 602
  • [44] 2-Aryl substituted pyridine C-region analogues of 2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides as highly potent TRPV1 antagonists
    Ryu, HyungChul
    Seo, Sejin
    Kim, Myeong Seop
    Kim, Mi-Yeon
    Kim, Ho Shin
    Ann, Jihyae
    Phuong-Thao Tran
    Van-Hai Hoang
    Byun, Jieun
    Cui, Minghua
    Son, Karam
    Sharma, Pankaz Kumar
    Choi, Sun
    Blumberg, Peter M.
    Frank-Foltyn, Robert
    Bahrenberg, Gregor
    Koegel, Babette-Yvonne
    Christoph, Thomas
    Frormann, Sven
    Lee, Jeewoo
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (16) : 4044 - 4047
  • [45] Repeated administration of vanilloid receptor TRPV1 antagonists attenuates hyperthermia elicited by TRPV1 blockade
    Gavva, Narender R.
    Bannon, Anthony W.
    Hovland, David N., Jr.
    Lehto, Sonya G.
    Klionsky, Lana
    Surapaneni, Sekhar
    Immke, David C.
    Henley, Charles
    Arik, Leyla
    Bak, Annette
    Davis, James
    Ernst, Nadia
    Hever, Gal
    Kuang, Rongzhen
    Shi, Licheng
    Tamir, Rami
    Wang, Jue
    Wang, Weiya
    Zajic, Gary
    Zhu, Dawn
    Norman, Mark H.
    Louis, Jean-Claude
    Magal, Ella
    Treanor, James J. S.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2007, 323 (01): : 128 - 137
  • [46] 2-Alkyl/alkenyl substituted pyridine C-region analogues of 2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides as highly potent TRPV1 antagonists
    Ryu, HyungChul
    Seo, Sejin
    Cho, Seong-Hee
    Kim, Ho Shin
    Jung, Aeran
    Kang, Dong Wook
    Son, Karam
    Cui, Minghua
    Hong, Sun-Hye
    Sharma, Pankaz Kumar
    Choi, Sun
    Blumberg, Peter M.
    Frank-Foltyn, Robert
    Bahrenberg, Gregor
    Stockhausen, Hannelore
    Schiene, Klaus
    Christoph, Thomas
    Frormann, Sven
    Lee, Jeewoo
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (16) : 4039 - 4043
  • [47] TRPV1 receptors in the CNS play a key role in broad-spectrum analgesia of TRPV1 antagonists
    Cui, M.
    Honore, P.
    Zhong, C.
    Gauvin, D.
    Mikusa, J.
    Hernandez, G.
    Chandran, P.
    Gomtsyan, A.
    Brown, B.
    Bayburt, E. K.
    Marsh, K.
    Bianchi, B.
    McDonald, H.
    Niforatos, W.
    Neelands, T. R.
    Moreland, R. B.
    Decker, M. W.
    Lee, C. -H.
    Sullivan, J. P.
    Faltynek, C. R.
    JOURNAL OF NEUROSCIENCE, 2006, 26 (37): : 9385 - 9393
  • [48] Emerging therapies for atopic dermatitis: TRPV1 antagonists
    Bonchak, Jonathan G.
    Swerlick, Robert A.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 78 (03) : S63 - S66
  • [49] Tetrahydropyridine-4-carboxamides as novel, potent transient receptor potential vanilloid 1 (TRPV1) antagonists
    Brown, Brian S.
    Keddy, Ryan
    Zheng, Guo Zhu
    Schmidt, Robert G.
    Koenig, John R.
    McDonald, Heath A.
    Bianchi, Bruce R.
    Honore, Prisca
    Jarvis, Michael F.
    Surowy, Carol S.
    Polakowski, James S.
    Marsh, Kennan C.
    Faltynek, Connie R.
    Lee, Chih-Hung
    BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (18) : 8516 - 8525
  • [50] Benzamide-type vanilloid (TRPV1) antagonists
    Appendino, G
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2006, 16 (04) : 549 - 553